DUBLIN, February 12, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/3jjvk6/developments_and) has announced the addition of the "Developments and Trends in Influenza Therapeutics (Technical Insights)" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Influenza is a burgeoning problem across the entire globe, there is an increased need for new therapeutic methods. A whole host of technology platforms are being utilized to create non egg based vaccines.
The world has not seen an influenza pandemic, and in terms of historical occurrences, we are several years overdue of one. There is a critical need for a universal vaccine, that has the potential to prevent multiple strains of influenza, so that yearly vaccinations can be eliminated and healthcare costs can be reduced.
The main focus of the research service features the influenza vaccine market and the types of emerging technologies as well as developing partnerships over 2010-2013.
The research service covers the following:
Key Topics Covered:
1. Executive Summary
2. Influenza Overview
3. R& D Portfolio Analysis - Vaccines By Technology
4. R& D Portfolio Analysis - Antivirals
5. Partnership & Alliances
6. R&D Budgetary Analysis
7. Environmental Analysis
8. Strategic Evaluation of Research and Development Portfolio
9. Contacts, Patents & DSD Tables
10. Appendix
11. Company Profile
For more information visit http://www.researchandmarkets.com/research/3jjvk6/developments_and
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article